Fraser Mary Clare
SEC CIK 1818882 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STE | Steris | VP, Chief HRO | 13.7K | — | — | 15 | 2021-10-01 | 2026-06-04 |
Most active insiders at STE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zangerle John Adam | SVP, Gen Counsel, Sec | — | $4.27M |
| 2 | Madsen Julia | SVP, GM, Life Sciences | — | $1.31M |
| 3 | Tamaro Renato | VP, Corp. Treas | — | $1.30M |
| 4 | Carestio Daniel A | Pres, CEO, Dir | — | $985.2K |
| 5 | Sohi Mohsen | Dir | — | $956.8K |
| 6 | FELDMANN CYNTHIA L | Dir | — | $734.9K |
| 7 | Breeden Richard C | Dir | — | $310.3K |
| 8 | McGowan Lindsey | VP, Chf. Comp, Quality Offc | — | — |
| 9 | Kohler Kenneth E | SVP, GM, AST | — | — |
| 10 | Fraser Mary Clare | SVP, Chief HRO | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:31 | 2026-06-04 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $212.24 | -600 | 13.7K | -4% | -$127.3K | |
| 2026-06-05 16:31 | 2026-06-03 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $210.19 | -311 | 14.3K | -2% | -$65.4K | |
| D | 2026-06-04 16:32 | 2026-06-02 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +3,009 | 15.2K | +25% | $0 |
| D | 2026-06-04 16:32 | 2026-06-02 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $209.76 | -591 | 14.6K | -4% | -$124.0K |
| 2026-06-03 16:40 | 2026-06-01 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $0.00 | -673 | 12.2K | -5% | $0 | |
| 2025-10-03 | 2025-10-01 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $0.00 | -207 | 12.9K | -2% | $0 | |
| D | 2025-06-05 | 2025-06-03 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +2,505 | 13.1K | +24% | $0 |
| 2025-06-04 | 2025-06-02 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $242.08 | -548 | 10.6K | -5% | -$132.7K | |
| D | 2024-06-06 | 2024-06-04 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +2,040 | 11.1K | +22% | $0 |
| 2024-06-05 | 2024-06-03 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $228.37 | -236 | 9,092 | -3% | -$53.9K | |
| 2023-06-05 | 2023-06-01 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $202.42 | -236 | 9,328 | -2% | -$47.8K | |
| D | 2023-06-02 | 2023-05-31 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +2,313 | 9,564 | +32% | $0 |
| D | 2022-06-03 | 2022-06-01 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $221.46 | -235 | 5,223 | -4% | -$52.0K |
| D | 2022-06-03 | 2022-06-02 | STE | Steris | Fraser Mary Clare | SVP, Chief HRO | A - Grant | $0.00 | +2,028 | 7,251 | +39% | $0 |
| D | 2021-10-05 | 2021-10-01 | STE | Steris | Fraser Mary Clare | VP, Chief HRO | A - Grant | $0.00 | +692 | 5,458 | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations